T cell-dependent activity of ganglioside GM1-specific B cells in Guillain-Barré syndrome and multifocal motor neuropathy in vitro

1994 ◽  
Vol 49 (1-2) ◽  
pp. 97-108 ◽  
Author(s):  
Fedor Heidenreich ◽  
Ludger Leifeld ◽  
Tudor Jovin
2015 ◽  
Vol 61 (01) ◽  
pp. 61-67
Author(s):  
Aida Loshaj-Shala ◽  
Ana Poceva Panovska ◽  
Katerina Brezovska ◽  
Giangiacomo Beretta ◽  
Ljubica Suturkova ◽  
...  

The evolutionary conserved family of heat shock proteins (HSP) is responsible for protecting cells against different types of stress. Although the levels of HSP can be readily measured in serum, the levels of HSP 70 in patients Guillain-Barre Syndrome (GBS) have not been studied before. To this aim we investigate whether patients with GBS (n=21) had altered serum HSP 70 levels compared to healthy controls (HC, n=9) and to patients affected by other immune disorders such as multifocal motor neuropathy (MMN, n=4) and chronic inflammatory demyelinating polyneuropathy (CIDP, n=6). The highest HSP 70 value (15.78 ± 1.72 ng/mL) was found in one patient in the GBS group, although we have found that serum HSP70 levels were significantly higher in 2 out of the 21 GBS patients (9.5%). Hence, it is of interest to underline that the patient with the highest HSP70 level, had also the best recovery rate. Моrе extensive research is required in order to support the hypothesis that HSP 70 serum concentration may be a useful biomarker for the prediction of remission outcome for GBS patients.


2014 ◽  
Vol 86 (5) ◽  
pp. 502-504 ◽  
Author(s):  
Elisabeth A Cats ◽  
W-Ludo van der Pol ◽  
Anne P Tio-Gillen ◽  
Frank P Diekstra ◽  
Leonard H van den Berg ◽  
...  

2021 ◽  
Vol 14 (3) ◽  
pp. e239977
Author(s):  
Kaushiki Kirty ◽  
Yashendu Sarda ◽  
Annu Jacob ◽  
Delanthabettu Venugopala

We report a case of a 26-year-old pregnant woman, who presented with subacute limb weakness. This was initially suspected to be Guillain-Barre syndrome but subsequently found to be the motor neuropathy of dry beriberi (vitamin B1, thiamine deficiency) along with associated Wernicke’s encephalopathy (WE). The underlying cause was revealed as hyperemesis gravidarum (HG). HG complicates up to 3% of pregnancies and if severe, without nutritional supplements, may lead to electrolyte disturbances, calorie loss and vitamin deficiency. Although the association of HG and WE was first reported in 1939, it remains an under diagnosed condition with potential for serious and permanent neurological deficits, and some mortality, in both mother and baby. Early recognition of the problem, with timely and careful fluid, electrolyte, glucose and vitamin replacement is needed to avoid complications. We highlight current best practice in the treatment of WE. An open mind to the possibility of HG complications in any pregnant woman presenting with neurological symptoms is probably the most important lesson to learn from the front line.


2020 ◽  
Vol 13 (2) ◽  
pp. e232940 ◽  
Author(s):  
Manisha Gulia ◽  
Preeti Dalal ◽  
Monica Gupta ◽  
Daljinderjit Kaur

Dengue is an arboviral infection that classically presents with fever, headache, joint pain, skin flush and morbilliform rashes. Neurological manifestations are well recognised but their exact incidence is unknown. Though myalgias are common in dengue virus infection, myositis and/or elevated serum creatine kinase is an uncommon complication. Guillain-Barré syndrome is another rare neurological manifestation associated with dengue fever. Here, we report the case of a 21-year-old man with serologically confirmed dengue fever presenting with severe myalgia, bilateral lower and upper limb weakness with raised creatine kinase, MRI suggestive of myositis and myonecrosis and nerve conduction velocity showing bilateral lower limb and axillary sensory motor neuropathy. He was managed conservatively and made an uneventful recovery.


1992 ◽  
Vol 111 (2) ◽  
pp. 200-203 ◽  
Author(s):  
A. Khalili-Shirazi ◽  
R.A.C. Hughes ◽  
S.W. Brostoff ◽  
C. Linington ◽  
N. Gregson

1997 ◽  
Vol 145 (2) ◽  
pp. 169-176 ◽  
Author(s):  
A Khalili-Shirazi ◽  
N.A Gregson ◽  
M.A Hall ◽  
R.A.C Hughes ◽  
J.S Lanchbury

Infection ◽  
2011 ◽  
Vol 40 (3) ◽  
pp. 323-326 ◽  
Author(s):  
I. Maurissen ◽  
A. Jeurissen ◽  
T. Strauven ◽  
D. Sprengers ◽  
B. De Schepper

2005 ◽  
Vol 12 (4) ◽  
pp. 409-415 ◽  
Author(s):  
Peter A. Csurhes ◽  
Alice-Ann Sullivan ◽  
Kerryn Green ◽  
Judith M. Greer ◽  
Michael P. Pender ◽  
...  

2021 ◽  
Author(s):  
Yang Sun ◽  
Yanjun Guo ◽  
Yaqing Wu ◽  
Ningning Luo ◽  
Xinjia He

Abstract Immunotherapy combinations have changed the treatment paradigm of advanced renal cell carcinoma (RCC). Notably, immunotherapy induces a new spectrum of immune-related adverse events (irAEs). Guillain–Barré syndrome (GBS) is a rare and potentially fatal nervous system irAE. The activation of T-cell is considered a triggering factor of GBS. We herein reported a case of GBS-like syndrome during treatment of tislelizumab and axitinib in a patient with RCC. To our knowledge, this is the first report of tislelizumab-related GBS.


Sign in / Sign up

Export Citation Format

Share Document